No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1wpuA_, 1.0000, 0.00, 1.000, 147, 147, CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA
2, d1wpuB_, 0.9996, 0.00, 1.000, 147, 147, CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA
3, d2gztC_, 0.9987, 0.08, 1.000, 147, 147,  
4, d3boyC_, 0.9985, 0.16, 1.000, 147, 147, CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO THE HUT MRNA
5, d3boyA_, 0.9985, 0.17, 1.000, 147, 147, CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO THE HUT MRNA
6, d1wpvA_, 0.9975, 0.17, 1.000, 147, 147, CRYSTAL STRUCTURE OF ACTIVATED BINARY COMPLEX OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
7, d1wpvC_, 0.9958, 0.23, 1.000, 147, 147, CRYSTAL STRUCTURE OF ACTIVATED BINARY COMPLEX OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
8, d1wpvB_, 0.9949, 0.30, 1.000, 147, 147, CRYSTAL STRUCTURE OF ACTIVATED BINARY COMPLEX OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
9, d1wroC_, 0.9938, 0.34, 1.000, 147, 147, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
10, d2gztB_, 0.9872, 0.40, 1.000, 147, 147,  
11, d3boyB_, 0.9868, 0.77, 1.000, 147, 147, CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO THE HUT MRNA
12, d1wrnA_, 0.9865, 0.79, 1.000, 147, 147, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
13, d1wroB_, 0.9856, 0.39, 1.000, 146, 146, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
14, d1wrnB_, 0.9854, 0.80, 1.000, 147, 147, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
15, d1wroA_, 0.9843, 0.41, 1.000, 146, 146, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
16, d1wrqB_, 0.9708, 0.81, 1.000, 147, 147, CRYSTAL STRUCTURE OF HUTP-ANTITERMINATION COMPLEX
17, d1wmqB_, 0.9707, 0.21, 1.000, 143, 143, STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA
18, d1wmqA_, 0.9699, 0.22, 1.000, 143, 143, STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA
19, d1wrqA_, 0.9698, 0.26, 1.000, 143, 143, CRYSTAL STRUCTURE OF HUTP-ANTITERMINATION COMPLEX
20, d2zh0C_, 0.9683, 0.27, 1.000, 143, 143,  
21, d1wrnC_, 0.9680, 0.31, 1.000, 143, 143, METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN HUTP FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS
22, d2zh0G_, 0.9676, 0.32, 1.000, 143, 143,  
23, d4h4lE_, 0.9654, 0.35, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
24, d2zh0N_, 0.9651, 0.40, 1.000, 143, 143,  
25, d4h4lB_, 0.9650, 0.41, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
26, d2zh0J_, 0.9646, 0.42, 1.000, 143, 143,  
27, d2zh0F_, 0.9639, 0.42, 1.000, 143, 143,  
28, d2zh0O_, 0.9629, 0.45, 1.000, 143, 143,  
29, d4h4lH_, 0.9617, 0.47, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
30, d4h4lK_, 0.9616, 0.50, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
31, d4h4lA_, 0.9615, 0.50, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
32, d2zh0K_, 0.9615, 0.50, 1.000, 143, 143,  
33, d4h4lF_, 0.9612, 0.50, 1.000, 143, 143, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
34, d2zh0H_, 0.9601, 0.52, 1.000, 143, 143,  
35, d2zh0B_, 0.9584, 0.36, 1.000, 142, 142,  
36, d2zh0L_, 0.9567, 0.41, 1.000, 142, 142,  
37, d2zh0P_, 0.9561, 0.45, 1.000, 142, 142,  
38, d4h4lD_, 0.9542, 0.46, 1.000, 142, 142, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
39, d4h4lL_, 0.9531, 0.52, 1.000, 142, 142, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
40, d4h4lJ_, 0.9525, 0.60, 0.979, 142, 142, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
41, d4h4lG_, 0.9504, 0.55, 1.000, 142, 142, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
42, d4h4lI_, 0.9489, 0.59, 1.000, 142, 142, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
43, d2zh0D_, 0.9385, 0.48, 0.986, 141, 141,  
44, d4h4lC_, 0.9374, 0.40, 1.000, 139, 139, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF HUTP(HUTP-L-HIS-ZN)
45, d4ok9A_, 0.9261, 0.43, 1.000, 139, 139, CRYSTAL STRUCTURE OF THE SINGLE-STRANDED RNA BINDING PROTEIN HUTP FROM GEOBACILLUS THERMODENITRIFICANS
46, d4okqB_, 0.9250, 1.69, 0.566, 146, 145, CRYSTAL STRUCTURE OF THE SINGLE-STRANDED RNA BINDING PROTEIN HUTP FROM GEOBACILLUS THERMODENITRIFICANS
47, d4okqA_, 0.9250, 1.61, 0.566, 146, 145, CRYSTAL STRUCTURE OF THE SINGLE-STRANDED RNA BINDING PROTEIN HUTP FROM GEOBACILLUS THERMODENITRIFICANS
48, d4ok9B_, 0.9244, 1.67, 0.566, 146, 145, CRYSTAL STRUCTURE OF THE SINGLE-STRANDED RNA BINDING PROTEIN HUTP FROM GEOBACILLUS THERMODENITRIFICANS
49, d1wptA_, 0.8613, 1.64, 0.566, 146, 145, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
50, d1wpsA_, 0.8607, 1.98, 0.951, 144, 142, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
51, d1veaA_, 0.8592, 1.86, 0.964, 143, 140, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTITERMINATION PROTEIN
52, d1veaB_, 0.8584, 1.95, 0.957, 143, 141, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTITERMINATION PROTEIN
53, d1wptB_, 0.8576, 2.32, 0.993, 144, 143, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
54, d1wpsB_, 0.8522, 2.33, 0.993, 144, 143, CRYSTAL STRUCTURE OF HUTP AN RNA BINDING ANTI-TERMINATION PROTEIN
55, p5c98A_, 0.5543, 2.38, 0.993, 144, 143, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
56, p5c98B_, 0.5540, 4.31, 0.097, 359, 124, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
57, d1db2B_, 0.5391, 4.30, 0.097, 364, 124, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
58, d1db2A_, 0.5361, 4.30, 0.097, 364, 124, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
59, d2behL_, 0.5357, 4.24, 0.106, 362, 123, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
60, d3kcgI_, 0.5354, 4.15, 0.107, 377, 122, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
61, d5brrI_, 0.5353, 4.38, 0.092, 403, 120, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
62, d3eoxA_, 0.5350, 4.03, 0.108, 419, 120, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
63, d3cvmA_, 0.5346, 4.33, 0.106, 372, 123, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
64, d1sr5A_, 0.5346, 4.50, 0.076, 370, 119, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
65, d1dzhL_, 0.5339, 4.37, 0.093, 377, 118, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
66, d1lk6L_, 0.5335, 4.01, 0.092, 409, 119, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
67, d1r1lL_, 0.5328, 4.41, 0.092, 407, 120, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
68, d2antL_, 0.5327, 4.41, 0.092, 406, 120, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
69, d4ic0B_, 0.5326, 4.34, 0.092, 409, 119, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
70, d4eb1L_, 0.5321, 4.31, 0.092, 398, 119, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
71, d1tb6I_, 0.5319, 4.23, 0.107, 358, 122, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
72, d3cvmB_, 0.5317, 4.40, 0.101, 392, 119, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
73, d4dteB_, 0.5316, 4.19, 0.091, 412, 121, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
74, d1c5gA_, 0.5315, 4.40, 0.093, 377, 118, PLASMINOGEN ACTIVATOR INHIBITOR-1
75, d4g8rA_, 0.5294, 4.19, 0.107, 364, 121, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
76, d1dvmD_, 0.5291, 4.35, 0.085, 379, 117, ACTIVE FORM OF HUMAN PAI-1
77, d4dteA_, 0.5289, 4.35, 0.085, 379, 117, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
78, d3ut3C_, 0.5289, 4.27, 0.107, 357, 122, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
79, d3r4lA_, 0.5289, 4.31, 0.107, 372, 122, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
80, d4g8oD1, 0.5288, 4.39, 0.090, 374, 122, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
81, d1dvmC_, 0.5288, 4.39, 0.090, 374, 122, ACTIVE FORM OF HUMAN PAI-1
82, d1dvmB_, 0.5286, 4.30, 0.107, 368, 122, ACTIVE FORM OF HUMAN PAI-1
83, d3ut3B_, 0.5285, 4.16, 0.107, 377, 121, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
84, d1lj5A_, 0.5284, 4.21, 0.107, 366, 121, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
85, d4g8oB1, 0.5281, 4.26, 0.107, 364, 122, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
86, d3ut3D_, 0.5277, 4.26, 0.107, 365, 122, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
87, d1lk6I_, 0.5271, 4.25, 0.107, 360, 122, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
88, d1br8I_, 0.5261, 4.34, 0.078, 379, 116, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
89, d1jrrA_, 0.5256, 4.22, 0.107, 358, 121, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
90, d3q03A_, 0.5254, 4.26, 0.107, 360, 122, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
91, p3f5nE_, 0.5253, 4.39, 0.101, 410, 119, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
92, p3f5nC_, 0.5252, 4.32, 0.102, 404, 118, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
93, d1e05I_, 0.5247, 4.45, 0.042, 357, 119, PLASMA ALPHA ANTITHROMBIN-III
94, d4dy7C_, 0.5245, 4.07, 0.092, 360, 119, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
95, d2arrA_, 0.5243, 4.14, 0.075, 340, 120, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
96, p3f5nD_, 0.5242, 4.13, 0.075, 358, 120, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
97, p3f5nA_, 0.5241, 4.24, 0.099, 417, 121, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
98, p3f5nB_, 0.5238, 4.08, 0.092, 377, 120, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
99, d1ovaA_, 0.5234, 4.46, 0.042, 358, 119, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
100, d1ovaD_, 0.5230, 4.17, 0.067, 363, 120, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
101, d1e04I_, 0.5230, 4.14, 0.075, 364, 120, PLASMA BETA ANTITHROMBIN-III
102, p4r9iA_, 0.5220, 4.14, 0.075, 366, 120, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
103, d1ovaC_, 0.5220, 4.34, 0.041, 383, 121, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
104, d4aqhA1, 0.5217, 4.36, 0.041, 385, 121, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
105, d2vh4B_, 0.5216, 4.36, 0.041, 385, 121, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
106, p3vvjC_, 0.5215, 4.18, 0.100, 403, 120, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
107, d8api.1, 0.5213, 4.32, 0.066, 378, 121, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
108, d4zk0A_, 0.5210, 4.32, 0.066, 378, 121, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
109, p3t1pA_, 0.5207, 4.35, 0.041, 373, 121, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
110, d1xqgB1, 0.5205, 4.40, 0.078, 379, 116, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
111, d2hijI1, 0.5202, 4.36, 0.094, 374, 117, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
112, d4p0oA_, 0.5201, 4.65, 0.067, 384, 120, CLEAVED SERPIN 42DA
113, d1wz9A_, 0.5199, 4.63, 0.102, 376, 118, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
114, p5io1B_, 0.5194, 4.53, 0.076, 367, 119, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
115, d1xu8A1, 0.5194, 4.54, 0.085, 340, 117, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
116, d1nq9I_, 0.5194, 4.33, 0.058, 375, 121, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
117, d2zv6B1, 0.5192, 4.33, 0.091, 411, 121, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
118, d1xu8B1, 0.5191, 4.54, 0.042, 371, 119, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
119, d1ovaB_, 0.5191, 4.54, 0.042, 371, 119, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
120, p5nctA_, 0.5182, 4.42, 0.057, 357, 123, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
121, d1br8L_, 0.5181, 4.30, 0.100, 364, 120, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
122, d1attB_, 0.5180, 4.40, 0.057, 364, 123, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
123, p4ga7A_, 0.5179, 4.20, 0.101, 406, 119, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
124, d3q02B_, 0.5178, 4.19, 0.067, 370, 119, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
125, d7api.1, 0.5174, 4.40, 0.057, 372, 123, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
126, p5ncwA_, 0.5171, 4.37, 0.041, 371, 121, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
127, d1imvA_, 0.5171, 4.61, 0.120, 325, 117, 2.85 A CRYSTAL STRUCTURE OF PEDF
128, d1xqgA1, 0.5168, 4.36, 0.043, 398, 117, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
129, d1uhgA_, 0.5168, 4.49, 0.076, 410, 119, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
130, p5cdzA_, 0.5165, 4.42, 0.090, 369, 122, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
131, p4if8A_, 0.5162, 4.35, 0.115, 362, 122, STRUCTURE OF VASPIN
132, d1oc0A_, 0.5156, 4.52, 0.095, 375, 116, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
133, d2d26A1, 0.5155, 4.59, 0.110, 334, 118, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
134, d1xqjA1, 0.5154, 4.22, 0.103, 375, 117, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
135, p5ncuA_, 0.5153, 4.22, 0.103, 375, 117, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
136, d2zv6C1, 0.5153, 4.44, 0.057, 375, 122, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
137, p4yiaA_, 0.5152, 4.44, 0.057, 375, 122, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
138, p4y40A_, 0.5151, 4.30, 0.042, 378, 119, STRUCTURE OF VASPIN MUTANT D305C V383C
139, d9paiA_, 0.5150, 4.40, 0.096, 361, 115, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
140, d2pefA_, 0.5147, 4.23, 0.101, 367, 119, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
141, d1i99I_, 0.5146, 4.49, 0.106, 364, 123,  
142, d2b5tI_, 0.5145, 4.35, 0.096, 336, 115, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
143, p3b9fI_, 0.5143, 4.35, 0.058, 375, 121, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
144, d1uhgC_, 0.5143, 4.56, 0.111, 329, 117, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
145, d2zv6A_, 0.5140, 4.25, 0.075, 349, 120, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
146, d2oayA1, 0.5138, 4.69, 0.067, 337, 119, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
147, d5ncsB1, 0.5133, 4.26, 0.101, 366, 119, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
148, p2xn7A_, 0.5130, 4.63, 0.067, 346, 119, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
149, d1jvqL_, 0.5129, 4.34, 0.095, 366, 116, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
150, p2xn6A_, 0.5127, 4.33, 0.091, 376, 121, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
151, p4y3kA_, 0.5125, 4.33, 0.091, 376, 121, STRUCTURE OF VASPIN MUTANT E379S
152, p3dy0A_, 0.5125, 4.47, 0.116, 415, 121, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
153, p2riwA_, 0.5125, 4.13, 0.093, 356, 118, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
154, p3zhaD_, 0.5123, 4.33, 0.042, 370, 119, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
155, p2xn5A_, 0.5123, 4.17, 0.076, 350, 119, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
156, p2xn3A_, 0.5121, 4.42, 0.061, 366, 115, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
157, d2vh4A_, 0.5121, 4.28, 0.118, 370, 119, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
158, p2rivA_, 0.5120, 4.55, 0.068, 339, 117, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
159, d1k9oI_, 0.5120, 4.41, 0.043, 406, 117, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
160, p2r9yA_, 0.5112, 4.62, 0.068, 337, 118, STRUCTURE OF ANTIPLASMIN
161, p5om7A1, 0.5111, 4.27, 0.101, 367, 119, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
162, d1wz9B_, 0.5110, 4.57, 0.085, 327, 117, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
163, p2hi9B_, 0.5108, 4.56, 0.068, 337, 117, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
164, p5ei0E_, 0.5106, 4.17, 0.092, 368, 119, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
165, p3fgqA_, 0.5104, 4.55, 0.068, 341, 117, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
166, d1qmb.1, 0.5104, 4.36, 0.089, 337, 112, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
167, p5ce0B_, 0.5102, 4.56, 0.094, 380, 117, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
168, d3cwlA_, 0.5099, 4.54, 0.068, 339, 117, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
169, d2qugA_, 0.5099, 4.33, 0.099, 376, 121, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
170, d5ncsA1, 0.5097, 4.35, 0.127, 365, 118, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
171, d1psiA_, 0.5097, 4.35, 0.127, 365, 118, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
172, d3evjI_, 0.5096, 4.65, 0.078, 250, 115, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
173, p5om2A1, 0.5093, 4.37, 0.058, 355, 120, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
174, d3ne4A_, 0.5093, 4.13, 0.093, 354, 118, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
175, d1sekA_, 0.5093, 4.52, 0.085, 371, 117, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
176, p4au2A_, 0.5092, 4.49, 0.074, 374, 122, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
177, d2peeA_, 0.5091, 4.49, 0.074, 374, 122, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
178, d4x30A_, 0.5086, 4.45, 0.102, 368, 118, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
179, p2ol2A_, 0.5086, 4.38, 0.084, 353, 119, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
180, p3zhaP_, 0.5085, 4.46, 0.083, 371, 120, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
181, d2vdxA_, 0.5085, 4.28, 0.092, 368, 119, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
182, d2peeB_, 0.5085, 4.44, 0.116, 370, 121, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
183, d3drmA_, 0.5084, 4.44, 0.116, 370, 121, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
184, p4ajuA_, 0.5082, 4.33, 0.084, 371, 119, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
185, d4c49C_, 0.5080, 4.30, 0.101, 404, 119, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
186, d1ophA_, 0.5080, 4.64, 0.070, 250, 115, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
187, d1lq8.4, 0.5080, 4.28, 0.092, 370, 119, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
188, p5ce0A_, 0.5079, 4.52, 0.098, 376, 122, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
189, d3f1sA_, 0.5078, 4.20, 0.101, 367, 119, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
190, p6ftpA1, 0.5077, 4.37, 0.083, 387, 121, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
191, p5om6C1, 0.5077, 4.37, 0.083, 387, 121, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
192, p2ol2B_, 0.5075, 4.21, 0.059, 372, 118, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
193, d4ro9B_, 0.5073, 4.21, 0.059, 372, 118, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
194, p4au4A_, 0.5071, 4.19, 0.076, 360, 118, CRYSTAL STRUCTURE OF HSP47
195, d1lq8.3, 0.5071, 4.19, 0.076, 360, 118, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
196, d4c49B_, 0.5070, 4.13, 0.110, 373, 118, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
197, p3zhaA_, 0.5069, 4.56, 0.051, 366, 117, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
198, d5hgcA1, 0.5068, 4.37, 0.091, 387, 121, A SERPIN STRUCTURE
199, d4ajtA_, 0.5068, 4.13, 0.085, 362, 117, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
200, p5cdxA_, 0.5066, 4.64, 0.051, 338, 118, CRYSTAL STRUCTURE OF CONSERPIN
201, p4bb2A1, 0.5064, 4.55, 0.043, 363, 115, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
202, d1hp7A_, 0.5064, 4.19, 0.102, 375, 118, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
203, d1oo8A_, 0.5059, 4.48, 0.069, 359, 116, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
204, d3cwmA_, 0.5053, 4.41, 0.092, 352, 120, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
205, d4ro9A_, 0.5052, 4.10, 0.059, 385, 118, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
206, p4afxA1, 0.5052, 4.10, 0.059, 385, 118, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
207, d3lw2A_, 0.5052, 4.55, 0.070, 242, 114, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
208, d5du3B_, 0.5050, 4.45, 0.071, 242, 113, ACTIVE FORM OF HUMAN C1-INHIBITOR
209, p2wxzA_, 0.5050, 4.17, 0.085, 343, 118, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
210, d1lq8.2, 0.5048, 4.37, 0.109, 348, 119, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
211, p4au4F_, 0.5047, 4.09, 0.127, 366, 118, CRYSTAL STRUCTURE OF HSP47
212, d5du3A_, 0.5046, 4.55, 0.077, 357, 117, ACTIVE FORM OF HUMAN C1-INHIBITOR
213, p5om3A1, 0.5044, 4.63, 0.052, 362, 116, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
214, p4au4E_, 0.5037, 4.14, 0.110, 380, 118, CRYSTAL STRUCTURE OF HSP47
215, p2wxzC_, 0.5036, 4.14, 0.110, 380, 118, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
216, d1dvnA_, 0.5036, 4.12, 0.069, 368, 116, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
217, d4ro9C_, 0.5034, 4.12, 0.069, 368, 116, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
218, p5om8A1, 0.5033, 4.13, 0.034, 372, 117, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
219, d5duqB_, 0.5033, 4.33, 0.092, 353, 119, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
220, p4au4G_, 0.5020, 4.72, 0.052, 266, 116, CRYSTAL STRUCTURE OF HSP47
221, p5om6A1, 0.5018, 4.41, 0.083, 376, 120, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
222, d1qlpA_, 0.5016, 4.41, 0.083, 376, 120, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
223, p4if8B_, 0.5014, 4.34, 0.092, 370, 119, STRUCTURE OF VASPIN
224, d5duqA_, 0.5012, 4.35, 0.084, 369, 119, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
225, p4au4D_, 0.5005, 4.30, 0.102, 353, 118, CRYSTAL STRUCTURE OF HSP47
